Post-Market BTVA Registry
Condition(s) studied
Investigational drug(s) / intervention(s)
Bronchoscopic Thermal Vapor Ablation: Bronchoscopic vapor delivery to airway segment(s) targeted for treatment
Study summary
Bronchoscopic thermal vapor ablation using Uptake Medical Technology Inc.'s InterVapor System is indicated for treatment of patients with heterogeneous upper lobe emphysema. This study is a retrospective and prospective, observational, multi-center, post-market registry of patients prescribed InterVapor. The primary objective of the Registry is to describe the long-term impact of InterVapor treatment on patient quality of life (QOL) in a real-world setting. After InterVapor treatment, patients will be followed for 5 years as per the standard of care and safety and efficacy data (quality of life, pulmonary function, exercise capacity) collected as part of the registry.
Eligibility
Primary outcome measure(s)
- Change in Quality of Life — Baseline to 24 months
Change in Quality of Life score as assessed by the SGRQ-C questionnaire
Trial sites (20)
| Facility | City | Region | Status |
|---|---|---|---|
| Krankenhaus Nord - Klinik Floridsdorf | Vienna | Austria | Recruiting |
| Sozialstiftung Bamberg, Klinikum am Bruderwald | Bamberg | Germany | Recruiting |
| DRK Kliniken Berlin / Mitte | Berlin | Germany | Recruiting |
| FORSCHUNGSINSTITUT Havelhöhe gGmbH | Berlin | Germany | Recruiting |
| Ruhrlandklinik - Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH | Essen | Germany | Recruiting |
| Asklepios Fachkliniken München-Gauting | Gauting | Germany | Recruiting |
| Martin-Luther-Universität Halle-Wittenberg (Saale) | Halle | Germany | Recruiting |
| Thoraxklinik Heidelberg | Heidelberg | Germany | Recruiting |
| Lungenklinik Hemer | Hemer | Germany | Recruiting |
| Lungenfachklinik Immenhausen | Immenhausen | Germany | Recruiting |
| Krankenhaus Martha-Maria München | München | Germany | Not Yet Recruiting |
| Klinikum Nürnberg Nord | Nuremberg | Germany | Recruiting |
| Krankenhaus vom Roten Kreuz Bad Cannstatt GmbH | Stuttgart | Germany | Recruiting |
| Klinik Schillerhöhe | Stuttgart | Germany | Recruiting |
| Kantonsspital Aarau AG | Aarau | Switzerland | Recruiting |
| University Hospital Basel | Basel | Switzerland | Not Yet Recruiting |
| Lungen-und Schlafzentrum am Lindenhofspital AG, Bern | Bern | Switzerland | Recruiting |
| Kantonsspital St.Gallen | Sankt Gallen | Switzerland | Withdrawn |
| LungenZentrum Hirslanden | Zurich | Switzerland | Recruiting |
| Universitäts Spital Zürich | Zurich | Switzerland | Recruiting |
More Uptake Medical Technology, Inc. trials in Austria
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03318406 on ClinicalTrials.gov ↗ ← All trials in Austria